Skip to content
Combined Shape Created with Sketch.
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • More
    • Events
    • Subscribe
    • About
    • Send a Tip
    • Advertising
    • Privacy Policy
  • COVID-19
  • EyewireTV
  • Stocks
  • Interests
    • Cataract and Refractive Eye-Grey Created with Sketch.
    • Glaucoma Gauge-Grey Created with Sketch.
    • Healthcare Cross-Grey Created with Sketch.
    • Optometry Laser-Grey Created with Sketch.
    • Product Approvals Gear-Grey Created with Sketch.
    • Retina Laser-Grey Created with Sketch.
  • Events
  • About
  • Send a Tip
  • Advertising
  • Privacy Policy

Retina

EDITExact DNA Integration TechnologyMacular degenerationSalioGen TherapeuticsBio-TissueCAMCryopreserved Amniotic MembraneCryopreserved Umbilical CordTissueTechTTBT01Ad26.COV2-ScoronavirusCOVID-19COVID-19 vaccineJohnson & Johnsondiabetic macular edemaDMEForbionOXU-001OxularAccure TherapeuticsACUITYacute optic neuritisAONEnvisionfellowshipGigi & Carl Allen Envision Research InstituteGeorge MarcellinoIRIDEXobitModernaSARS-CoV-2variantHorizon TherapeuticsTEDthyroid eye disease

View More Tags +

View Content By Tag

Latest News

03.01.21

SalioGen Therapeutics Announces Closing of $20 Million Series A Financing to Advance Gene Therapies

Source: SalioGen Therapeutics

03.01.21

Bio-Tissue Receives FDA Clearance to Proceed with Clinical Study Using Investigational New Drug TTBT01

Source: Bio-Tissue

03.01.21

J&J’s COVID-19 Vaccine Wins FDA Authorization for Emergency Use

Source: FirstWord

03.01.21

Retinal Therapeutics Development Company Oxular Completes $37 Million (£27 million) Financing

Source: Oxular

03.01.21

Accure Therapeutics Enrolls First Patient in Phase 2 Clinical Trial on Acute Optic Neuritis

Source: Accure Therapeutics

02.26.21

Envision Announces Call for Applications for Next Class of Research Fellows

Source: Envision

02.25.21

Remembering Ophthalmic Industry Executive George Marcellino

Source: Iridex

02.25.21

Moderna’s Variant-Specific COVID-19 Vaccine Candidate Ready for Clinical Testing

Source: FirstWord

02.24.21

New Survey Assessment Finds Debilitating Impact of Thyroid Eye Disease (TED) on Quality of Life Continues Beyond Acute Disease into Chronic Phase

Source: Horizon Therapeutics

02.24.21

One-Dose J&J COVID-19 Vaccine Meets Criteria as Safe and Effective, FDA Report Finds

Source: USA Today

View more stories

Home

Menu

Share

  • Cataract and Refractive
  • Cornea
  • Glaucoma
  • Healthcare
  • Innovation
  • Optometry
  • Product Approvals
  • Retina
  • Events
  • About
  • Send a Tip
  • Advertising
  • Contact
  • EyewireTV
  • Stocks
  • Privacy Policy
Created with Sketch. Created with Sketch. Created with Sketch. Created with Sketch.
eyewire-news-color bmc-mark Created with Sketch.

© 2021 Bryn Mawr Communications, LLC.

All Rights Reserved.